Leukocyte telomere length and mycophenolate therapy in chronic hypersensitivity pneumonitis-Reference-Cited by-同舟云学术

Leukocyte telomere length and mycophenolate therapy in chronic hypersensitivity pneumonitis

Published:2020-10-29 Issue:3 Volume:57 Page:2002872
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

Adegunsoye Ayodeji,Morisset Julie,Newton Chad A.,Oldham Justin M.,Vittinghoff Eric,Linderholm Angela L.,Strek Mary E.,Noth Imre,Garcia Christine Kim,Wolters Paul J.,Ley Brett

Funder

National Heart, Lung, and Blood Institute

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference14 articles.

1. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

2. A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

3. Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

4. Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis

5. Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine;American Journal of Respiratory and Critical Care Medicine;2024-08-15

2. The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions;American Journal of Respiratory and Critical Care Medicine;2024-08-15

3. Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease;Biomedicines;2024-06-21

4. Syndromic genetic causes of pulmonary fibrosis;Current Opinion in Pulmonary Medicine;2024-06-19

5. Clinical Impact of Telomere Length Testing for Interstitial Lung Disease;CHEST;2024-06